Use specialist drugs under close specialist supervision only and monitor patients taking these drugs
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
-
Gastroenterology and Cancer (MET3A) (Year 3)
- SDL & CE: Pharmacological Management of Inflammatory Bowel Disease (Priority 2)
Assessment
This learning outcome is assessed in the following ways:
- NOT YET CATEGORISED
